Literature DB >> 29588780

Renal Sympathetic Denervation - A Review of Applications in Current Practice.

Vikas Kapil1,2, Ajay K Jain1,3, Melvin D Lobo1,2.   

Abstract

Resistant hypertension is associated with high morbidity and mortality despite numerous pharmacological strategies. A wealth of preclinical and clinical data have demonstrated that resistant hypertension is associated with elevated renal and central sympathetic tone. The development of interventional therapies to modulate the sympathetic nervous system potentially represents a paradigm shift in the strategy for blood pressure control in this subset of patients. Initial first-in-man and pivotal, randomised controlled trials of endovascular, radio-frequency renal sympathetic denervation have spawned numerous iterations of similar technology, as well as many novel concepts for achieving effective renal sympatholysis. This review details the current knowledge of these devices and the evidence base behind each technology.

Entities:  

Keywords:  Hypertension; devices; renal sympathectomy; resistant

Year:  2014        PMID: 29588780      PMCID: PMC5808654          DOI: 10.15420/icr.2011.9.1.54

Source DB:  PubMed          Journal:  Interv Cardiol        ISSN: 1756-1485


  88 in total

1.  Cryogenic surgery: a new method of destruction or extirpation of benign or malignant tissues.

Authors:  I S COPPER
Journal:  N Engl J Med       Date:  1963-04-04       Impact factor: 91.245

Review 2.  Functional role of renal afferents.

Authors:  A Stella; A Zanchetti
Journal:  Physiol Rev       Date:  1991-07       Impact factor: 37.312

3.  Effect of treatment with botulinum toxin on spasticity.

Authors:  T K Das; D M Park
Journal:  Postgrad Med J       Date:  1989-04       Impact factor: 2.401

4.  Renal sympathetic denervation as second-line therapy in mild resistant hypertension: a pilot study.

Authors:  Benjamin Kaltenbach; Jennifer Franke; Stefan C Bertog; Daniel H Steinberg; Ilona Hofmann; Horst Sievert
Journal:  Catheter Cardiovasc Interv       Date:  2012-08-13       Impact factor: 2.692

5.  Noninvasive renal sympathetic denervation by extracorporeal high-intensity focused ultrasound in a pre-clinical canine model.

Authors:  Qifeng Wang; Rui Guo; Shunkang Rong; Gang Yang; Que Zhu; Yonghong Jiang; Changming Deng; Dichuan Liu; Qi Zhou; Qi Wu; Shunhe Wang; Jun Qian; Qi Wang; Han Lei; Tong-Chuan He; Zhibiao Wang; Jing Huang
Journal:  J Am Coll Cardiol       Date:  2013-03-26       Impact factor: 24.094

6.  Renal denervation in moderate treatment-resistant hypertension.

Authors:  Christian Ott; Felix Mahfoud; Axel Schmid; Tilmann Ditting; Paul A Sobotka; Roland Veelken; Aline Spies; Christian Ukena; Ulrich Laufs; Michael Uder; Michael Böhm; Roland E Schmieder
Journal:  J Am Coll Cardiol       Date:  2013-07-10       Impact factor: 24.094

7.  First human experience with pulmonary vein isolation using a through-the-balloon circumferential ultrasound ablation system for recurrent atrial fibrillation.

Authors:  A Natale; E Pisano; J Shewchik; D Bash; R Fanelli; D Potenza; P Santarelli; R Schweikert; R White; W Saliba; L Kanagaratnam; P Tchou; M Lesh
Journal:  Circulation       Date:  2000-10-17       Impact factor: 29.690

8.  Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study.

Authors:  Henry Krum; Markus P Schlaich; Paul A Sobotka; Michael Böhm; Felix Mahfoud; Krishna Rocha-Singh; Richard Katholi; Murray D Esler
Journal:  Lancet       Date:  2013-11-07       Impact factor: 79.321

9.  Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.

Authors:  David A Calhoun; Daniel Jones; Stephen Textor; David C Goff; Timothy P Murphy; Robert D Toto; Anthony White; William C Cushman; William White; Domenic Sica; Keith Ferdinand; Thomas D Giles; Bonita Falkner; Robert M Carey
Journal:  Hypertension       Date:  2008-04-07       Impact factor: 10.190

10.  2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Authors:  Giuseppe Mancia; Robert Fagard; Krzysztof Narkiewicz; Josep Redon; Alberto Zanchetti; Michael Böhm; Thierry Christiaens; Renata Cifkova; Guy De Backer; Anna Dominiczak; Maurizio Galderisi; Diederick E Grobbee; Tiny Jaarsma; Paulus Kirchhof; Sverre E Kjeldsen; Stéphane Laurent; Athanasios J Manolis; Peter M Nilsson; Luis Miguel Ruilope; Roland E Schmieder; Per Anton Sirnes; Peter Sleight; Margus Viigimaa; Bernard Waeber; Faiez Zannad; Josep Redon; Anna Dominiczak; Krzysztof Narkiewicz; Peter M Nilsson; Michel Burnier; Margus Viigimaa; Ettore Ambrosioni; Mark Caufield; Antonio Coca; Michael Hecht Olsen; Roland E Schmieder; Costas Tsioufis; Philippe van de Borne; Jose Luis Zamorano; Stephan Achenbach; Helmut Baumgartner; Jeroen J Bax; Héctor Bueno; Veronica Dean; Christi Deaton; Cetin Erol; Robert Fagard; Roberto Ferrari; David Hasdai; Arno W Hoes; Paulus Kirchhof; Juhani Knuuti; Philippe Kolh; Patrizio Lancellotti; Ales Linhart; Petros Nihoyannopoulos; Massimo F Piepoli; Piotr Ponikowski; Per Anton Sirnes; Juan Luis Tamargo; Michal Tendera; Adam Torbicki; William Wijns; Stephan Windecker; Denis L Clement; Antonio Coca; Thierry C Gillebert; Michal Tendera; Enrico Agabiti Rosei; Ettore Ambrosioni; Stefan D Anker; Johann Bauersachs; Jana Brguljan Hitij; Mark Caulfield; Marc De Buyzere; Sabina De Geest; Geneviève Anne Derumeaux; Serap Erdine; Csaba Farsang; Christian Funck-Brentano; Vjekoslav Gerc; Giuseppe Germano; Stephan Gielen; Herman Haller; Arno W Hoes; Jens Jordan; Thomas Kahan; Michel Komajda; Dragan Lovic; Heiko Mahrholdt; Michael Hecht Olsen; Jan Ostergren; Gianfranco Parati; Joep Perk; Jorge Polonia; Bogdan A Popescu; Zeljko Reiner; Lars Rydén; Yuriy Sirenko; Alice Stanton; Harry Struijker-Boudier; Costas Tsioufis; Philippe van de Borne; Charalambos Vlachopoulos; Massimo Volpe; David A Wood
Journal:  Eur Heart J       Date:  2013-06-14       Impact factor: 29.983

View more
  2 in total

1.  Joint UK societies' 2014 consensus statement on renal denervation for resistant hypertension.

Authors:  Melvin D Lobo; Mark A de Belder; Trevor Cleveland; David Collier; Indranil Dasgupta; John Deanfield; Vikas Kapil; Charles Knight; Matthew Matson; Jonathan Moss; Julian F R Paton; Neil Poulter; Iain Simpson; Bryan Williams; Mark J Caulfield
Journal:  Heart       Date:  2014-11-27       Impact factor: 5.994

Review 2.  Interventional procedures and future drug therapy for hypertension.

Authors:  Melvin D Lobo; Paul A Sobotka; Atul Pathak
Journal:  Eur Heart J       Date:  2017-04-14       Impact factor: 29.983

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.